Zimmer Partners, LP Evolus, Inc. Transaction History
Zimmer Partners, LP
- $5.42 Billion
- Q4 2024
A detailed history of Zimmer Partners, LP transactions in Evolus, Inc. stock. As of the latest transaction made, Zimmer Partners, LP holds 416,500 shares of EOLS stock, worth $6.14 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
416,500
Previous 250,000
66.6%
Holding current value
$6.14 Million
Previous $4.05 Million
13.53%
% of portfolio
0.08%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding EOLS
# of Institutions
168Shares Held
48.7MCall Options Held
129KPut Options Held
54K-
Perceptive Advisors LLC New York, NY5.15MShares$75.8 Million1.9% of portfolio
-
Tang Capital Management LLC San Diego, CA5MShares$73.7 Million4.14% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$59.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.17MShares$46.7 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.13MShares$46.1 Million1.74% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $827M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...